NCT06890702View on ClinicalTrials.gov

Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease

Not yet recruitingOBSERVATIONAL

Enrollment

7,000

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 27, 2035

Study Completion Date

January 1, 2038

Conditions

Ischemic StrokeIschemic Cerebrovascular Disease

Interventions

DIAGNOSTIC_TEST

biomaker levels

this study will discover and validate novel biomarkers (including urine, feces, cerebrospinal fluid, blood, plaques, emboli, drainage fluid, bone marrow, lymph nodes and brain tissue etc al) of ischemic cerebrovascular disease

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER

NCT06890702 - Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease | Biotech Hunter | Biotech Hunter